WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.
Teng. Y Y; Mei. Y Y; Hawthorn. L L; Cowell. J K JK
Key Findings
- WASF3 increases ZEB1/2 and suppresses KISS1, promoting cancer cell invasion
- KISS1 normally blocks NFÎşB activity, helping prevent metastasis
- Knocking down WASF3 restores miR‑200 and E‑cadherin, reducing invasiveness
Practical Outcomes
- For most health‑optimizing individuals, this research doesn’t provide a usable protocol or dosage. It highlights a potential future target (WASF3) for anti‑cancer strategies, but no immediate actions can be taken with kisspeptin‑10 for longevity or performance.
Summary
The study shows that a protein called WASF3 can make breast cancer cells more invasive by lowering the levels of another protein, kisspeptin (KISS1), which normally helps keep cells from spreading. When WASF3 is high, it boosts ZEB1/2, which shuts down a micro‑RNA cluster that protects against invasion, leading to more aggressive cancer behavior. Reducing WASF3 levels reverses these effects and makes the cells less invasive.
Abstract
The WASF3 gene promotes invasion and metastasis in breast cancer cells, which have undergone epithelial-to-mesenchyme transition (EMT). Overexpression of WASF3 in cells that do not show EMT increases their invasion potential as a result of increased ZEB1/2 levels, which specifically suppress the anti-invasion chromosome 1 miR-200a/200b/429 cluster. ZEB1/2 upregulation by WASF3 results from downregulation of KISS1, leading to the release of inhibition of nuclear factor (NF)κB by IκBα. We further show that ZEB1 expression is regulated by the NFκB transcription factor. Knockdown of WASF3 in breast cancer cells leads to reduced ZEB1 levels and increased miR-200 and E-cadherin levels, resulting in loss of invasion potential. The central regulation of this interactive pathway by WASF3 accounts for the increased invasion associated with increased WASF3 expression seen in aggressive breast cancer cells. WASF3, therefore, is a potential target to suppress invasion and metastasis in breast cancer cells.
Study Information
pubmed
2013
2013-01-14T00:00:00.000Z
10.1038/onc.2012.565
76
46